Carlsmed (CARL) Current Assets (2024 - 2026)

Carlsmed (CARL) has 3 years of Current Assets data on file, last reported at $115.4 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets changed N/A year-over-year to $115.4 million; the trailing twelve-month figure through Mar 2026 stood at $115.4 million (changed N/A YoY), and the FY2025 full-year result was $126.7 million, up 156.68% from the prior year.
• Current Assets for Q1 2026 stood at $115.4 million, down from $126.7 million in the prior quarter.
• Across five years, Current Assets topped out at $131.5 million in Q3 2025 and bottomed at $46.2 million in Q2 2025.
• The 3-year median for Current Assets is $115.4 million (2026), against an average of $93.8 million.
• Peak annual rise in Current Assets reached 156.68% in 2025, while the deepest fall reached 156.68% in 2025.
• A 3-year view of Current Assets shows it stood at $49.4 million in 2024, then soared by 156.68% to $126.7 million in 2025, then declined by 8.89% to $115.4 million in 2026.
• The last three Current Assets figures came in at $115.4 million (Q1 2026), $126.7 million (Q4 2025), and $131.5 million (Q3 2025), per Business Quant data.

Peer Comparison